Implementation of a Gestational Diabetes Virtual Care Clinic: A Before-After Comparative Study.

IF 2.6 3区医学 Q2 Medicine

Diabetes Therapy Pub Date : 2026-04-01 Epub Date: 2026-03-10 DOI:10.1007/s13300-026-01845-9

Ciara Coveney, Shauna Callaghan, Eimear Rutter, Catherine Chambers, Joy Adekanmbi, Hannah Rooney, Ricardo Segurado, Mary F Higgins, Mensud Hatunic

{"title":"Implementation of a Gestational Diabetes Virtual Care Clinic: A Before-After Comparative Study.","authors":"Ciara Coveney, Shauna Callaghan, Eimear Rutter, Catherine Chambers, Joy Adekanmbi, Hannah Rooney, Ricardo Segurado, Mary F Higgins, Mensud Hatunic","doi":"10.1007/s13300-026-01845-9","DOIUrl":null,"url":null,"abstract":"Introduction: Gestational diabetes mellitus (GDM) is common diagnosis during pregnancy and has a substantial effect on maternal and fetal morbidity. Advancements in healthcare technology, such as Bluetooth-enabled glucometers, telemedicine, and virtual clinics, have emerged as efficient tools for GDM management.Methods: This is a retrospective study of clinical outcomes in women with GDM across two time points (January-June 2019 and January-June 2021) following the introduction of a virtual care pathway in a tertiary referral maternity hospital. Demographic, GDM management and birth outcomes data were collected anonymously from electronic hospital records and analysed.Results: A total of 583 patients were included, 2019 (n = 227) and 2021 (n = 356). We found higher rates of attendance at GDM education via the virtual platform (99.4% vs 95.6%, p < 0.01), faster access to GDM care and initiation of treatment (p < 0.001) in 2021.Conclusion: Our study shows higher rates of attendance at our virtual GDM education pathway led to a faster initiation of pharmacological therapy.","PeriodicalId":11192,"journal":{"name":"Diabetes Therapy","volume":" ","pages":"563-570"},"PeriodicalIF":2.6000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13103148/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13300-026-01845-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Gestational diabetes mellitus (GDM) is common diagnosis during pregnancy and has a substantial effect on maternal and fetal morbidity. Advancements in healthcare technology, such as Bluetooth-enabled glucometers, telemedicine, and virtual clinics, have emerged as efficient tools for GDM management.

Methods: This is a retrospective study of clinical outcomes in women with GDM across two time points (January-June 2019 and January-June 2021) following the introduction of a virtual care pathway in a tertiary referral maternity hospital. Demographic, GDM management and birth outcomes data were collected anonymously from electronic hospital records and analysed.

Results: A total of 583 patients were included, 2019 (n = 227) and 2021 (n = 356). We found higher rates of attendance at GDM education via the virtual platform (99.4% vs 95.6%, p < 0.01), faster access to GDM care and initiation of treatment (p < 0.001) in 2021.

Conclusion: Our study shows higher rates of attendance at our virtual GDM education pathway led to a faster initiation of pharmacological therapy.

查看原文本刊更多论文

妊娠期糖尿病虚拟护理诊所的实施：前后比较研究。

妊娠期糖尿病（GDM）是妊娠期的常见病，对孕产妇和胎儿的发病率有重要影响。医疗保健技术的进步，如蓝牙血糖仪、远程医疗和虚拟诊所，已经成为管理GDM的有效工具。方法：这是一项回顾性研究，在一家三级转诊妇产医院引入虚拟护理途径后，对两个时间点（2019年1月至6月和2021年1月至6月）的GDM女性临床结果进行研究。从电子医院记录中匿名收集人口统计、GDM管理和出生结局数据并进行分析。结果：共纳入583例患者，2019年（n = 227）和2021年（n = 356）。我们发现，通过虚拟平台进行GDM教育的出勤率更高（99.4% vs 95.6%）。结论：我们的研究表明，虚拟GDM教育途径的出勤率更高，可以更快地启动药物治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes Therapy Medicine-Endocrinology, Diabetes and Metabolism

CiteScore

6.90

自引率

7.90%

发文量

130

审稿时长

6 weeks

期刊介绍： Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.